CD5 and diabetes mellitus: In mice, FasL can be induced by TLR4 activation in CD5+CD1d+ Bregs (65) and in the NOD mouse model can be activated with LPS (TLR4), resulting in TGFβ production, which inhibits Th1 responses and diabetes progression (63).